Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Pancreas|June 28, 2011
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic massesSofiya Reicher, Fatih Z Boyar, Maher Albitar, et al.British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.Blood|August 27, 2005
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemiaStefan Faderl, Kim-Anh Do, Marcella M Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemiaWilliam Wierda, Susan O'Brien, Sijin Wen, et al.Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.Blood|August 28, 2009
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseFrancis Giles, Norbert Vey, Daniel DeAngelo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responsesJorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.Pageof 21